Literature DB >> 27091806

Pulmonary sarcoidosis induced by the anti-PD1 monoclonal antibody pembrolizumab.

S Cousin1, M Toulmonde1, M Kind2, A-L Cazeau3, D Bechade4, J-M Coindre5, A Italiano6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27091806     DOI： 10.1093/annonc/mdw125

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  16 in total

1.  Managing Pulmonary Toxicities Associated with Immunotherapy: A Case Discussion.

Authors:  Vanessa A Reed; Naiyer Rizvi
Journal:  Oncologist       Date:  2019-03-21

2.  Pathology of immune-mediated tissue lesions following treatment with immune checkpoint inhibitors.

Authors:  Hajir Ibraheim; Esperanza Perucha; Nick Powell
Journal:  Rheumatology (Oxford)       Date:  2019-12-01       Impact factor: 7.580

Review 3.  Sarcoid-like reaction in cases treated by checkpoint inhibitors.

Authors:  Semra Paydas
Journal:  Med Oncol       Date:  2021-02-18       Impact factor: 3.064

4.  Suspected immune checkpoint inhibitor-induced pulmonary sarcoid reaction in metastatic renal cell carcinoma.

Authors:  Victoria Purcell; Beatrice Preti; Ricardo Fernandes
Journal:  Clin Case Rep       Date:  2022-07-11

Review 5.  Immunopathogenesis of granulomas in chronic autoinflammatory diseases.

Authors:  Wilhelmina Maria Cornelia Timmermans; Jan Alexander Michael van Laar; Petrus Martinus van Hagen; Menno Cornelis van Zelm
Journal:  Clin Transl Immunology       Date:  2016-12-16

6.  Sarcoidosis in the setting of combination ipilimumab and nivolumab immunotherapy: a case report & review of the literature.

Authors:  Joshua E Reuss; Paul R Kunk; Anne M Stowman; Alejandro A Gru; Craig L Slingluff; Elizabeth M Gaughan
Journal:  J Immunother Cancer       Date:  2016-12-20       Impact factor: 13.751

7.  Pembrolizumab-induced pneumonitis.

Authors:  Vincent Leroy; Carole Templier; Jean-Baptiste Faivre; Arnaud Scherpereel; Clement Fournier; Laurent Mortier; Lidwine Wemeau-Stervinou
Journal:  ERJ Open Res       Date:  2017-05-02

8.  Pulmonary Sarcoidosis Activation following Neoadjuvant Pembrolizumab plus Chemotherapy Combination Therapy in a Patient with Non-Small Cell Lung Cancer: A Case Report.

Authors:  Ghina Fakhri; Reem Akel; Ziad Salem; Ayman Tawil; Arafat Tfayli
Journal:  Case Rep Oncol       Date:  2017-11-27

9.  Thoracic and cutaneous sarcoid-like reaction associated with anti-PD-1 therapy: longitudinal monitoring of PD-1 and PD-L1 expression after stopping treatment.

Authors:  Léa Paolini; Caroline Poli; Simon Blanchard; Thierry Urban; Anne Croué; Marie-Christine Rousselet; Sarah Le Roux; Nathalie Labarrière; Pascale Jeannin; José Hureaux
Journal:  J Immunother Cancer       Date:  2018-06-13       Impact factor: 13.751

10.  Sarcoid-Like Granulomatosis Induced by Nivolumab Treatment in a Lung Cancer Patient.

Authors:  Susumu Noguchi; Hiroaki Kawachi; Hiroshi Yoshida; Akari Fukao; Satoshi Terashita; Tatsuyoshi Ikeue; Sadao Horikawa; Takakazu Sugita
Journal:  Case Rep Oncol       Date:  2018-08-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.